Money Concepts Capital’s iBio IBIO Stock Holding History

Money Concepts Capital’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-65	Closed	-$34K	–	739
2020 Q4	$34K	Buy	+65	New	+$53K	﹤0.01%	545

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Money Concepts Capital's IBIO Position: Q1 2021 in Review

Money Concepts Capital sold out of iBio (IBIO) in Q1 2021, closing a stake of 65 shares — an estimated $34K sold.

Money Concepts Capital first reported a position in IBIO in Q4 2020 and held it in 1 quarter. The position peaked at $34K in Q4 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

Money Concepts Capital reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
Money Concepts Capital sold 65 iBio shares in Q1 2021, an estimated $34K.
Money Concepts Capital first reported a position in iBio in Q4 2020 and held it in 1 quarter.
Money Concepts Capital's iBio position peaked at $34K in Q4 2020.
91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Money Concepts Capital's 13F filing for Q1 2021, filed 17 May 2021.